Not logged in Multiscale profiling of tyrosine kinase inhibitor cardiotoxicity reveals mechanosensitive ion channel PIEZO1 as cardioprotective Manhas, Amit; Liu, Yu; Noishiki, Chikage; Wu, David; Tripathi, Dipti; Mirza, Sarah; Thomas, Dilip; Liu, Lu; Guha, Avirup; Nguyen, Patricia K.; Chen, Ian Y.; Chitalia, Vipul; Cheng, Paul; Sayed, Danish; Telli, Melinda L.; Sallam, Karim; Wu, Joseph C.; Sayed, Nazish Share Save
Breast Cancer, Version 5.2025 Featured Updates to the NCCN Guidelines Gradishar, William J.; Moran, Meena S.; Abraham, Jame; Abramson, Vandana; Aft, Rebecca; Agnese, Doreen; Allison, Kimberly H.; Anderson, Bethany; Bailey, Janet; Burstein, Harold J.; Chen, Nan; Chew, Helen; Dang, Chau; Elias, Anthony D.; Giordano, Sharon H.; Goetz, Matthew P.; Jankowitz, Rachel C.; Javid, Sara H.; Krishnamurthy, Jairam; Leitch, A. Marilyn; Lyons, Janice; McCloskey, Susie; McShane, Melissa; Mortimer, Joanne; Patel, Sameer A.; Rosenberger, Laura H.; Rugo, Hope S.; Santa-Maria, Cesar A.; Schneider, Bryan P.; Smith, Mary Lou; Soliman, Hatem; Stringer-Reasor, Erica M.; Telli, Melinda L.; Wei, Mei; Wisinski, Kari B.; Yellala, Amulya; Yeung, Kay T.; Young, Jessica S.; Schonfeld, Ryan; Kumar, Rashmi Share Save
Share Save
Share Save
Share Save
Share Save
Breast Cancer, Version 3.2024 Gradishar, William J.; Moran, Meena S.; Abraham, Jame; Abramson, Vandana; Aft, Rebecca; Agnese, Doreen; Allison, Kimberly H.; Anderson, Bethany; Bailey, Janet; Burstein, Harold J.; Chen, Nan; Chew, Helen; Dang, Chau; Elias, Anthony D.; Giordano, Sharon H.; Goetz, Matthew P.; Jankowitz, Rachel C.; Javid, Sara H.; Krishnamurthy, Jairam; Leitch, A. Marilyn; Lyons, Janice; McCloskey, Susie; Mcshane, Melissa; Mortimer, Joanne; Patel, Sameer A.; Rosenberger, Laura H.; Rugo, Hope S.; Santa-Maria, Cesar; Schneider, Bryan P.; Smith, Mary Lou; Soliman, Hatem; Stringer-Reasor, Erica M.; Telli, Melinda L.; Wei, Mei; Wisinski, Kari B.; Yeung, Kay T.; Young, Jessica S.; Schonfeld, Ryan; Kumar, Rashmi Share Save
Neoadjuvant talazoparib in patients with germline BRCA1/2 mutation-positive, early-stage triple-negative breast cancer: exploration of tumor BRCA mutational status Telli, Melinda L.; Litton, Jennifer K.; Beck, J. Thaddeus; Jones, Jason M.; Andersen, Jay; Mina, Lida A.; Brig, Raymond; Danso, Michael; Yuan, Yuan; Symmans, William F.; Hopkins, Julia F.; Albacker, Lee A.; Abbattista, Antonello; Noonan, Kay; Mata, Marielena; Laird, A. Douglas; Blum, Joanne L. Share Save
MORPHEUS Hormone Receptor-Positive Breast Cancer: interim analysis of a Phase Ib/II, study of fulvestrant ± atezolizumab and abemaciclib triplet treatment in patients metastatic disease Jung, Kyung Hae; Im, Seock-Ah; Yardley, Denise; Hurvitz, Sara; Lee, Keun Seok; Sonnenblick, Amir; Shachar, Shlomit; Tan, Antoinette; Comen, Elizabeth; Gal-Yam, Einav; Brufsky, Adam; Rugo, Hope; Zhu, Jing; DuPree, Kelly; Breton, Vanessa; Young, Fiona; Schwab, Richard; Cha, Edward; Telli, Melinda Share Save
Vepdegestrant, a PROteolysis TArgeting Chimera (PROTAC) estrogen receptor (ER) degrader, plus palbociclib in ER-positive/human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer: phase 1b cohort Hamilton, Erika; Jeselsohn, Rinath; Hurvitz, Sara; Juric, Dejan; Han, Hyo; Telli, Melinda; Zahrah, George; Nanda, Rita; Zhang, Yuanyuan; Tan, Weiwei; Duperret, Elizabeth; Zhi, Eric; Mather, Cecile; Schott, Anne Share Save
Predicting outcomes in locally advanced breast cancer through profiling post-neoadjuvant tissue-based minimal residual disease Ransohoff, Julia; Carleton, Mia; Birk, Alisha; Bean, Gregory; Telli, Melinda; Alizadeh, Ash; Ford, James; Duran, George; Khodadoust, Michael; Kurtz, David Share Save
Interim analysis of giredestrant plus inavolisib in MORPHEUS Breast Cancer: a Phase Ib/II study of giredestrant treatment combinations in estrogen receptor-positive, HER2-negative, locally advanced/metastatic breast cancer Rugo, Hope; Gion, Maria; Hernando, Cristina; Jung, Kyung Hae; Oliveira, Mafalda; Telli, Melinda; Vidal, Gregory; Vatandoust, Sina; Zhu, Jing; Schwab, Richard; Ngo, Huy; Ferreira, Erika; Collier, Ann; Breton, Vanessa; Gal-Yam, Einav Share Save
Updated results from VERITAC evaluating vepdegestrant, a PROteolysis TArgeting Chimera (PROTAC) estrogen receptor (ER) degrader, in ER- positive/human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer Hurvitz, Sara; Schott, Anne; Ma, Cynthia; Nanda, Rita; Zahrah, George; Hunter, Natasha; Tan, Antoinette; Telli, Melinda; Mesias, Jesus Anampa; Jeselsohn, Rinath; Munster, Pamela; Zhi, Eric; Duperret, Elizabeth; Mather, Cecile; Hamilton, Erika; Han, Hyo Share Save
Molecular characterization and therapeutic approach for VISTA plus triple-negative breast cancers Zhao, Yan; Charles, Fatima; Lipchik, Andrew; Peng, Yan; Ford, James; Telli, Melinda; Zhang, Song; Kurian, Allison; Snyder, Michael; Gruber, Joshua Share Save
Share Save
Phase 3 study of neoadjuvant pembrolizumab or placebo plus chemotherapy, followed by adjuvant pembrolizumab or placebo plus endocrine therapy for early-stage high-risk ER+/ HER2-breast cancer: KEYNOTE-756 Cardoso, Fatima; O'Shaughnessy, Joyce; McArthur, Heather; Schmid, Peter; Cortes, Javier; Harbeck, Nadia; Telli, Melinda; Cescon, David; Fasching, Peter A.; Shao, Zhimin; Loirat, Delphine; Park, Yeon Hee; Fernandez, Manuel Gonzalez; Rubovszky, Gabor; Im, Seock-Ah; Hui, Rina; Takano, Toshimi; Andre, Fabrice; Yasojima, Hiroyuki; Liu, Zhenzhen; Ding, Yu; Jia, Liyi; Karantza, Vassiliki; Tryfonidis, Konstantinos; Bardia, Aditya Share Save
Share Save
A radiogenomic approach for triple-negative breast cancer risk stratification Noor, Humaira; Zheng, Yuanning; Mantz, Adam; Zhou, Ryle; Kozlov, Andrew; DeMartini, Wendy B.; Chen, Shu-Tian; Okamoto, Satoko; Ikeda, Debra; Mattonen, Sarah; Napel, Sandy; Telli, Melinda L.; Sledge, George; Kurian, Allison; Satoyoshi, Mina; Gevaert, Olivier; Itakura, Haruka Share Save
Genomic analysis of advanced breast cancer tumors from talazoparib-treated gBRCA1/2mut carriers in the ABRAZO study Turner, Nicholas C.; Laird, A. Douglas; Telli, Melinda L.; Rugo, Hope S.; Mailliez, Audrey; Ettl, Johannes; Grischke, Eva-Maria; Mina, Lida A.; Balmana, Judith; Fasching, Peter A.; Hurvitz, Sara A.; Hopkins, Julia F.; Albacker, Lee A.; Chelliserry, Jijumon; Chen, Ying; Conte, Umberto; Wardley, Andrew M.; Robson, Mark E. Share Save
KEYNOTE-756: Phase III study of neoadjuvant pembrolizumab (pembro) or placebo (pbo) plus chemotherapy (chemo), followed by adjuvant pembro or pbo plus endocrine therapy (ET) for early-stage high-risk ER+/HER2e breast cancer Cardoso, F.; McArthur, H. L.; Schmid, P.; Cortes, J.; Harbeck, N.; Telli, M. L.; Cescon, D. W.; O'Shaughnessy, J.; Fasching, P.; Shao, Z.; Loirat, D.; Park, Y. H.; Fernandez, M. E. Gonzalez; Liu, Z.; Yasojima, H.; Ding, Y.; Jia, L.; Karantza, V. V.; Tryfonidis, K. E.; Bardia, A. Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
